Novartis Bioventures Ltd
Insider CIK 1297709 · CLDN 10% owner · ALT 10% owner · TKAI 10% owner · ALRN 10% owner · NONE 10% owner · PTI 10% owner · RARX 10% owner · AKBA 10% owner · GRTX 10% owner · AGLE 10% owner · AKUS · BCYC 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 856,262 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 199,996 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | P Buy | 2020-06-30 | 2020-07-02 | 125,000 | $17.00 | $2.13M | 1,181,258 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-02 | 199,996 | — | $0 | 1,056,258 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-02 | 856,262 | — | $0 | 856,262 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | S Sale | 2020-06-19 | 2020-06-22 | 1,001,312 | $8.25 | $8.26M | 2,467,961 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | S Sale | 2020-06-18 | 2020-06-22 | 900 | $9.04 | $8.1K | 3,469,273 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | S Sale | 2020-06-17 | 2020-06-17 | 4,622 | $9.27 | $42.8K | 3,470,173 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | S Sale | 2020-06-16 | 2020-06-17 | 8,600 | $9.30 | $80.0K | 3,474,795 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | S Sale | 2020-06-15 | 2020-06-17 | 6,164 | $9.05 | $55.8K | 3,483,395 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | S Sale | 2020-06-12 | 2020-06-12 | 1,500 | $9.19 | $13.8K | 3,489,559 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | S Sale | 2020-06-11 | 2020-06-12 | 7,200 | $9.21 | $66.3K | 3,491,059 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | S Sale | 2020-06-10 | 2020-06-12 | 8,532 | $9.46 | $80.7K | 3,498,259 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | S Sale | 2020-06-09 | 2020-06-09 | 7,000 | $9.38 | $65.7K | 3,506,791 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | S Sale | 2020-06-08 | 2020-06-09 | 5,659 | $9.66 | $54.7K | 3,513,791 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | S Sale | 2020-06-05 | 2020-06-09 | 8,652 | $9.66 | $83.6K | 3,519,450 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | S Sale | 2020-06-04 | 2020-06-04 | 4,088 | $9.55 | $39.0K | 3,528,102 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | S Sale | 2020-06-03 | 2020-06-04 | 5,208 | $9.78 | $50.9K | 3,532,190 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | S Sale | 2020-06-02 | 2020-06-04 | 5,669 | $9.68 | $54.9K | 3,537,398 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 7,200,000 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 451,609 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 9,000,000 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | P Buy | 2019-11-12 | 2019-11-12 | 250,000 | $12.00 | $3.00M | 3,543,067 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2019-11-12 | 2019-11-12 | 3,293,067 | — | $0 | 3,293,067 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | C Conversion deriv | 2019-05-28 | 2019-05-30 | 636,366 | — | $0 | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | X Exercise deriv | 2019-05-28 | 2019-05-30 | 71,450 | — | $0 | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | C Conversion deriv | 2019-05-28 | 2019-05-30 | 893,195 | — | $0 | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | C Conversion | 2019-05-28 | 2019-05-30 | 636,366 | — | $0 | 1,601,011 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | C Conversion | 2019-05-28 | 2019-05-30 | 893,195 | — | $0 | 893,195 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | X Exercise | 2019-05-28 | 2019-05-30 | 71,450 | — | $0 | 964,645 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | P Buy | 2019-05-28 | 2019-05-30 | 168,630 | $14.00 | $2.36M | 1,769,641 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-04-26 | 2019-04-29 | 138,704 | $1.03 | $142.9K | 4,049,804 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-04-25 | 2019-04-29 | 563,096 | $1.03 | $580.0K | 4,188,508 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-04-24 | 2019-04-24 | 16,403 | $1.03 | $16.9K | 4,751,604 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-04-23 | 2019-04-24 | 27,554 | $1.03 | $28.4K | 4,768,007 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-04-22 | 2019-04-24 | 7,100 | $0.97 | $6.9K | 4,795,561 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-04-15 | 2019-04-15 | 28,794 | $0.99 | $28.5K | 4,802,661 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-04-12 | 2019-04-15 | 30,908 | $1.04 | $32.1K | 4,831,455 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-04-11 | 2019-04-15 | 57,438 | $1.08 | $62.0K | 4,862,363 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-04-10 | 2019-04-10 | 140,230 | $1.09 | $152.9K | 4,919,801 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-04-09 | 2019-04-10 | 32,991 | $1.01 | $33.3K | 5,060,031 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-04-08 | 2019-04-10 | 27,525 | $1.02 | $28.1K | 5,093,022 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-04-05 | 2019-04-05 | 24,661 | $1.02 | $25.2K | 5,120,547 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-04-04 | 2019-04-05 | 47,900 | $1.01 | $48.4K | 5,145,208 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-04-03 | 2019-04-05 | 58,033 | $0.96 | $55.7K | 5,193,108 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-04-02 | 2019-04-02 | 51,754 | $0.97 | $50.2K | 5,251,141 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-04-01 | 2019-04-02 | 116,909 | $0.95 | $111.1K | 5,302,895 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2019-04-01 | 2019-04-02 | 20,610 | $1.90 | $39.2K | 2,079,394 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-03-29 | 2019-04-02 | 63,100 | $0.91 | $57.4K | 5,419,804 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2019-03-29 | 2019-04-02 | 106,540 | $1.85 | $197.1K | 2,100,004 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-03-28 | 2019-03-28 | 88,835 | $0.94 | $83.5K | 5,482,904 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-03-27 | 2019-03-28 | 50,749 | $0.99 | $50.2K | 5,571,739 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2019-03-26 | 2019-03-28 | 177,762 | $1.01 | $179.5K | 5,622,488 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2019-03-15 | 2019-03-15 | 43,800 | $1.92 | $84.1K | 2,206,544 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2019-03-14 | 2019-03-15 | 13,800 | $1.88 | $25.9K | 2,250,344 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2019-03-13 | 2019-03-15 | 132,738 | $2.12 | $281.4K | 2,264,144 | SEC↗ |
| ALT Altimmune, Inc. | J Other deriv | 2018-09-12 | 2018-09-14 | 465,086 | — | $0 | 0 | SEC↗ |
| ALT Altimmune, Inc. | J Other | 2018-09-12 | 2018-09-14 | 2,069,993 | — | $0 | 8,345,145 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2018-08-20 | 2018-08-22 | 5,300 | $3.90 | $20.7K | 5,800,250 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-08-20 | 2018-08-22 | 20,388 | $2.30 | $46.9K | 2,396,882 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-08-17 | 2018-08-20 | 8,700 | $2.10 | $18.3K | 2,417,270 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-08-16 | 2018-08-20 | 8,808 | $2.10 | $18.5K | 2,425,970 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-08-15 | 2018-08-16 | 2,635 | $2.15 | $5.7K | 2,434,778 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-08-14 | 2018-08-16 | 3,300 | $2.26 | $7.5K | 2,437,413 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-08-13 | 2018-08-14 | 1,600 | $2.36 | $3.8K | 2,440,713 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-08-10 | 2018-08-14 | 5,615 | $2.44 | $13.7K | 2,442,313 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-08-09 | 2018-08-10 | 235 | $2.48 | $583 | 2,447,928 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-08-08 | 2018-08-10 | 1,000 | $2.78 | $2.8K | 2,448,163 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-08-07 | 2018-08-08 | 1,739 | $2.97 | $5.2K | 2,449,163 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-08-06 | 2018-08-08 | 2,942 | $3.02 | $8.9K | 2,450,902 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-08-02 | 2018-08-06 | 4,702 | $3.33 | $15.7K | 2,453,844 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-08-01 | 2018-08-02 | 8,181 | $3.22 | $26.3K | 2,458,546 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-07-31 | 2018-08-02 | 4,500 | $3.07 | $13.8K | 2,466,727 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-07-30 | 2018-07-31 | 2,000 | $3.27 | $6.5K | 2,471,227 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-07-27 | 2018-07-31 | 6,458 | $3.38 | $21.8K | 2,473,227 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-07-26 | 2018-07-27 | 7,937 | $3.63 | $28.8K | 2,479,685 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-07-25 | 2018-07-27 | 12,460 | $3.84 | $47.8K | 2,487,622 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-07-24 | 2018-07-25 | 700 | $4.11 | $2.9K | 2,500,082 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-07-23 | 2018-07-25 | 30,600 | $4.25 | $130.1K | 2,500,782 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-07-17 | 2018-07-18 | 12,500 | $4.71 | $58.9K | 2,531,382 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | S Sale | 2018-07-16 | 2018-07-18 | 300 | $5.15 | $1.5K | 2,543,882 | SEC↗ |
| ALT Altimmune, Inc. | J Other deriv | 2018-07-11 | 2018-07-13 | 345 | $940.00 | $324.2K | 0 | SEC↗ |
| ALT Altimmune, Inc. | J Other | 2018-07-11 | 2018-07-13 | 663,346 | — | $0 | 6,275,152 | SEC↗ |
| ALT Altimmune, Inc. | J Other | 2018-06-15 | 2018-06-19 | 14,449 | — | $0 | 5,611,806 | SEC↗ |
| ALT Altimmune, Inc. | J Other deriv | 2018-06-13 | 2018-06-15 | 345 | — | $0 | 345 | SEC↗ |
| ALT Altimmune, Inc. | J Other | 2018-06-13 | 2018-06-15 | 720,878 | — | $0 | 5,597,357 | SEC↗ |
| ALT Altimmune, Inc. | J Other deriv | 2018-05-16 | 2018-05-17 | 345 | — | $0 | 690 | SEC↗ |
| ALT Altimmune, Inc. | J Other | 2018-05-16 | 2018-05-17 | 767,728 | — | $0 | 4,876,479 | SEC↗ |
| ALT Altimmune, Inc. | J Other | 2018-05-15 | 2018-05-17 | 274,703 | — | $0 | 4,108,751 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | S Sale | 2018-05-11 | 2018-05-14 | 19,550 | $10.06 | $196.7K | 2,175,314 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | S Sale | 2018-05-10 | 2018-05-11 | 22,725 | $10.13 | $230.2K | 2,194,864 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | S Sale | 2018-05-09 | 2018-05-11 | 51,230 | $10.11 | $517.9K | 2,217,589 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | S Sale | 2018-05-08 | 2018-05-09 | 26,557 | $10.03 | $266.4K | 2,268,819 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | S Sale | 2018-05-07 | 2018-05-09 | 15,548 | $10.11 | $157.2K | 2,295,376 | SEC↗ |
| ALT Altimmune, Inc. | J Other deriv | 2018-04-16 | 2018-04-18 | 345 | — | $0 | 1,035 | SEC↗ |
| ALT Altimmune, Inc. | J Other | 2018-04-16 | 2018-04-18 | 217,159 | — | $0 | 3,834,048 | SEC↗ |
| ALT Altimmune, Inc. | J Other | 2018-04-16 | 2018-04-18 | 482,907 | — | $0 | 3,616,889 | SEC↗ |
| ALT Altimmune, Inc. | J Other deriv | 2018-03-15 | 2018-03-19 | 345 | — | $0 | 1,380 | SEC↗ |
| ALT Altimmune, Inc. | J Other | 2018-03-15 | 2018-03-19 | 261,969 | — | $0 | 3,133,982 | SEC↗ |
| ALT Altimmune, Inc. | J Other | 2018-02-15 | 2018-02-15 | 67,925 | — | $0 | 2,872,013 | SEC↗ |
| ALT Altimmune, Inc. | J Other deriv | 2018-02-13 | 2018-02-15 | 345 | — | $0 | 1,725 | SEC↗ |
| ALT Altimmune, Inc. | J Other | 2018-02-13 | 2018-02-15 | 269,527 | — | $0 | 2,804,088 | SEC↗ |
| ALT Altimmune, Inc. | J Other deriv | 2018-01-17 | 2018-01-19 | 345 | — | $0 | 2,070 | SEC↗ |
| ALT Altimmune, Inc. | J Other | 2018-01-17 | 2018-01-19 | 176,586 | — | $0 | 2,534,561 | SEC↗ |
| ALT Altimmune, Inc. | J Other | 2017-12-15 | 2017-12-15 | 65,718 | — | $0 | 2,357,975 | SEC↗ |
| ALT Altimmune, Inc. | J Other deriv | 2017-12-13 | 2017-12-15 | 345 | — | $0 | 2,415 | SEC↗ |
| ALT Altimmune, Inc. | J Other | 2017-12-13 | 2017-12-15 | 242,694 | — | $0 | 2,292,257 | SEC↗ |
| ALT Altimmune, Inc. | J Other deriv | 2017-11-14 | 2017-11-16 | 345 | — | $0 | 2,760 | SEC↗ |
| ALT Altimmune, Inc. | J Other | 2017-11-14 | 2017-11-16 | 182,262 | — | $0 | 2,049,563 | SEC↗ |
| ALT Altimmune, Inc. | P Buy deriv | 2017-08-21 | 2017-08-23 | 465,086 | — | $0 | 465,086 | SEC↗ |
| ALT Altimmune, Inc. | P Buy deriv | 2017-08-21 | 2017-08-23 | 3,104 | $940.00 | $2.92M | 3,104 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-05 | 4,238,607 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-05 | 2,967,025 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-05 | 6,781,770 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-05 | 2,644,558 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-05 | 2,293,829 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-05 | 3,705,882 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | P Buy | 2017-07-05 | 2017-07-05 | 266,667 | $15.00 | $4.00M | 2,544,182 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion | 2017-07-05 | 2017-07-05 | 2,277,515 | — | $0 | 2,277,515 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-06-19 | 2017-06-20 | 3,220 | $22.02 | $70.9K | 2,251,457 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-06-16 | 2017-06-20 | 53,200 | $21.24 | $1.13M | 2,254,677 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-06-08 | 2017-06-12 | 700 | $22.00 | $15.4K | 2,307,877 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-06-07 | 2017-06-08 | 4,840 | $22.11 | $107.0K | 2,308,577 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-06-06 | 2017-06-08 | 7,274 | $22.98 | $167.2K | 2,313,417 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-06-05 | 2017-06-06 | 4,780 | $23.11 | $110.5K | 2,320,691 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-06-02 | 2017-06-06 | 14,867 | $23.47 | $348.9K | 2,325,471 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-06-01 | 2017-06-02 | 10,722 | $23.89 | $256.1K | 2,340,338 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-05-31 | 2017-06-02 | 35,539 | $23.94 | $850.8K | 2,351,060 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-05-26 | 2017-05-30 | 5,300 | $25.14 | $133.2K | 2,386,599 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-05-25 | 2017-05-30 | 53 | $25.00 | $1.3K | 2,391,899 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-05-24 | 2017-05-25 | 17,451 | $25.01 | $436.4K | 2,391,952 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-05-18 | 2017-05-22 | 9,019 | $25.50 | $230.0K | 2,409,403 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-05-17 | 2017-05-18 | 22,534 | $25.51 | $574.8K | 2,418,422 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-05-16 | 2017-05-18 | 20,081 | $26.33 | $528.7K | 2,440,956 | SEC↗ |
| NONE Aerpio Pharmaceuticals, In | P Buy | 2017-03-15 | 2017-03-17 | 560,000 | $5.00 | $2.80M | 5,805,550 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-03-01 | 2017-05-02 | 7,778 | $20.91 | $162.6K | 2,461,037 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-02-28 | 2017-05-02 | 7,847 | $20.86 | $163.7K | 2,468,815 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-02-27 | 2017-05-02 | 57,844 | $20.96 | $1.21M | 2,476,662 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-02-24 | 2017-05-02 | 5,398 | $20.93 | $113.0K | 2,534,506 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-02-23 | 2017-05-02 | 4,999 | $21.04 | $105.2K | 2,539,904 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2017-02-22 | 2017-05-02 | 749 | $21.86 | $16.4K | 2,544,903 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 3,402,729 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | X Exercise deriv | 2016-10-31 | 2016-10-31 | 62,914 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 9,728,589 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 3,657,932 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | P Buy | 2016-10-31 | 2016-10-31 | 84,615 | $13.00 | $1.10M | 2,545,652 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | X Exercise | 2016-10-31 | 2016-10-31 | 62,914 | $0.07 | $4.4K | 62,914 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 486,104 | — | $0 | 2,461,037 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 522,561 | — | $0 | 1,974,933 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 1,389,797 | — | $0 | 1,452,372 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2016-10-31 | 2016-10-31 | 339 | $13.00 | $4.4K | 62,575 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | C Conversion deriv | 2016-04-12 | 2016-04-12 | 1,120,448 | — | $0 | 0 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | C Conversion deriv | 2016-04-12 | 2016-04-12 | 890,476 | — | $0 | 0 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2016-04-12 | 2016-04-12 | 300,000 | $10.00 | $3.00M | 2,310,924 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | C Conversion | 2016-04-12 | 2016-04-12 | 2,010,924 | — | $0 | 2,010,924 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | C Conversion deriv | 2016-02-17 | 2016-02-17 | 10,000,000 | — | $0 | 0 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | C Conversion deriv | 2016-02-17 | 2016-02-17 | 1,944,315 | — | $0 | 0 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | C Conversion | 2016-02-17 | 2016-02-17 | 1,498,791 | — | $0 | 1,498,791 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-02-17 | 2016-02-17 | 375,000 | $8.00 | $3.00M | 1,873,791 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | S Sale | 2015-07-15 | 2015-07-17 | 3,566 | $14.26 | $50.9K | 4,493,458 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | S Sale | 2015-07-14 | 2015-07-15 | 27,861 | $14.41 | $401.5K | 4,497,024 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | S Sale | 2015-07-13 | 2015-07-15 | 20,611 | $14.20 | $292.7K | 4,524,885 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | S Sale | 2015-06-16 | 2015-06-18 | 1,120 | $14.27 | $16.0K | 4,545,496 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | S Sale | 2015-06-12 | 2015-06-16 | 5,919 | $14.20 | $84.0K | 4,561,393 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | S Sale | 2015-06-11 | 2015-06-12 | 27,875 | $14.20 | $395.8K | 4,567,312 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | S Sale | 2015-03-19 | 2015-03-20 | 46,141 | $14.50 | $669.0K | 4,595,187 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | S Sale | 2015-03-18 | 2015-03-20 | 3,000 | $14.50 | $43.5K | 4,641,328 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | C Conversion deriv | 2014-09-22 | 2014-09-24 | 1,539,643 | — | $0 | 0 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | C Conversion deriv | 2014-09-22 | 2014-09-24 | 15,064,469 | — | $0 | 0 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | C Conversion deriv | 2014-09-22 | 2014-09-24 | 13,222,826 | — | $0 | 0 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | C Conversion deriv | 2014-09-22 | 2014-09-24 | 15,396,431 | — | $0 | 0 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | C Conversion | 2014-09-22 | 2014-09-24 | 4,319,328 | — | $0 | 4,319,328 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | P Buy | 2014-09-22 | 2014-09-24 | 325,000 | $15.00 | $4.88M | 4,644,328 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | S Sale | 2014-06-15 | 2015-06-16 | 14,777 | $14.20 | $209.8K | 4,546,616 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | C Conversion deriv | 2014-03-25 | 2014-03-27 | 347,831 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | C Conversion deriv | 2014-03-25 | 2014-03-27 | 708,647 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | C Conversion deriv | 2014-03-25 | 2014-03-27 | 257,031 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | C Conversion | 2014-03-25 | 2014-03-27 | 3,223,174 | — | $0 | 3,405,764 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-03-25 | 2014-03-27 | 182,590 | $17.00 | $3.10M | 182,590 | SEC↗ |
| CLDN Celladon Corp | C Conversion deriv | 2014-02-04 | 2014-02-06 | 25,481 | — | $0 | 25,481 | SEC↗ |
| CLDN Celladon Corp | C Conversion deriv | 2014-02-04 | 2014-02-06 | 318,266 | — | $0 | 0 | SEC↗ |
| CLDN Celladon Corp | C Conversion deriv | 2014-02-04 | 2014-02-06 | 16,537 | $8.00 | $132.3K | 0 | SEC↗ |
| CLDN Celladon Corp | C Conversion deriv | 2014-02-04 | 2014-02-06 | 17,146,250 | — | $0 | 0 | SEC↗ |
| CLDN Celladon Corp | C Conversion | 2014-02-04 | 2014-02-06 | 1,372,798 | — | $0 | 1,372,798 | SEC↗ |
| CLDN Celladon Corp | P Buy | 2014-02-04 | 2014-02-06 | 162,386 | $8.00 | $1.30M | 1,551,721 | SEC↗ |
| CLDN Celladon Corp | C Conversion | 2014-02-04 | 2014-02-06 | 16,537 | $8.00 | $132.3K | 1,389,335 | SEC↗ |